Eldred Rock Partners LLC raised its position in shares of Lam Research Corporation (NASDAQ:LRCX – Free Report) by 6.4% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 71,251 shares of the semiconductor company’s stock after acquiring an additional 4,289 shares during the period. Lam Research makes up 6.6% of Eldred Rock Partners LLC’s portfolio, making the stock its biggest position. Eldred Rock Partners LLC’s holdings in Lam Research were worth $30,875,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in LRCX. Fideuram Asset Management Ireland dac acquired a new stake in Lam Research in the 4th quarter valued at $10,035,000. Generali Investments Management Co LLC raised its position in Lam Research by 62.0% in the fourth quarter. Generali Investments Management Co LLC now owns 36,274 shares of the semiconductor company’s stock valued at $6,209,000 after purchasing an additional 13,878 shares during the period. Rokos Capital Management LLP lifted its stake in shares of Lam Research by 42.0% during the first quarter. Rokos Capital Management LLP now owns 259,921 shares of the semiconductor company’s stock worth $55,532,000 after purchasing an additional 76,840 shares in the last quarter. Aware Super Pty Ltd as trustee of Aware Super purchased a new stake in shares of Lam Research in the first quarter worth about $59,973,000. Finally, Krilogy Financial LLC boosted its position in shares of Lam Research by 19.5% in the first quarter. Krilogy Financial LLC now owns 28,111 shares of the semiconductor company’s stock worth $6,006,000 after buying an additional 4,584 shares during the period. 84.61% of the stock is currently owned by institutional investors and hedge funds.
Lam Research Price Performance
Shares of NASDAQ LRCX opened at $311.35 on Friday. Lam Research Corporation has a fifty-two week low of $94.11 and a fifty-two week high of $438.50. The business has a 50 day moving average price of $339.89 and a two-hundred day moving average price of $279.64. The company has a quick ratio of 1.91, a current ratio of 2.63 and a debt-to-equity ratio of 0.30. The firm has a market cap of $389.36 billion, a PE ratio of 54.05, a price-to-earnings-growth ratio of 1.22 and a beta of 1.84.
Lam Research Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Wednesday, July 8th. Investors of record on Wednesday, June 17th were issued a $0.26 dividend. The ex-dividend date of this dividend was Wednesday, June 17th. This represents a $1.04 annualized dividend and a yield of 0.3%. Lam Research’s dividend payout ratio is currently 18.06%.
Wall Street Analyst Weigh In
LRCX has been the topic of several analyst reports. HSBC reiterated a “hold” rating and set a $333.00 target price on shares of Lam Research in a report on Monday, July 27th. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $290.00 price objective on shares of Lam Research in a research report on Thursday, April 23rd. Mizuho lifted their price objective on shares of Lam Research from $380.00 to $400.00 and gave the company an “outperform” rating in a research note on Thursday, July 9th. Zacks Research raised shares of Lam Research from a “hold” rating to a “strong-buy” rating in a research report on Friday, July 17th. Finally, Wall Street Zen downgraded shares of Lam Research from a “buy” rating to a “hold” rating in a research note on Sunday, May 10th. One investment analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $358.47.
View Our Latest Stock Analysis on Lam Research
Insider Buying and Selling at Lam Research
In other Lam Research news, Director Eric Brandt sold 54,500 shares of the firm’s stock in a transaction on Thursday, June 11th. The shares were sold at an average price of $350.80, for a total transaction of $19,118,600.00. Following the completion of the transaction, the director directly owned 199,205 shares of the company’s stock, valued at $69,881,114. This trade represents a 21.48% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Abhijit Y. Talwalkar sold 18,282 shares of the business’s stock in a transaction dated Monday, July 13th. The stock was sold at an average price of $335.00, for a total transaction of $6,124,470.00. Following the completion of the sale, the director directly owned 87,142 shares of the company’s stock, valued at $29,192,570. The trade was a 17.34% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 80,441 shares of company stock worth $27,614,296 in the last ninety days. 0.31% of the stock is owned by insiders.
About Lam Research
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Featured Articles
- Five stocks we like better than Lam Research
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
